From the database of
Essential Science IndicatorsSM, this list of Fast
Moving Fronts has been generated by a comparison of the data sets for the
current period of January 2004-December 31, 2009, and the previous period
of November 2003-October 31, 2009 (sliding 6-year period).
Research Front Maps may be selected from the current Research Front set
that are relevant to the core papers of the chosen field.
them at the site-wide listing of all Research Front Maps (sorted by field.
This symbol indicates that the author(s) of the comments
below have also sent along accompanying images/descriptions of their
Low dose curcumin effectively disaggregates amyloid beta as
well as prevents fibril and oligomer formation, supporting the
rationale for curcumin use in clinical trials preventing or
treating Alzheimer's disease.
C-H BOND ACTIVATION; N-HETEROCYCLE C-H
ACTIVATION; DIRECT C-2 SELECTIVE ALKENYLATION;
PALLADIUM-CATALYZED C-H FUNCTIONALIZATION